Heidi B. Capozzi
Heidi B. Capozzi's purchase track record
How the stock did after each of Heidi B. Capozzi's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/23/2024 | CVS | $2K | -6.7% | +18.1% | -7.3% |
| 10/2/2024 | CVS | $622 | -28.2% | +12.0% | -0.7% |
| 9/9/2024 | CVS | $2K | +0.4% | +18.3% | +2.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
McDonald's Dividend Raise Seen as Fair Value Signal. McDonald's recently raised its dividend, with analysts suggesting the stock may now be trading near fair value. While the company offers a yield above 3%, recent coverage highlights a lack of strong growth catalysts beyond the payout. The stock currently sits within a wide 52-week range, reflecting mixed sentiment on its future performance.
Transaction History
| CVS | ▼ Sell | Tax Withholding | 1,334 | $97K | 4/1/2026 | View on chart |
| CVS | ▲ Buy | Grant | 10,025 | $720K | 3/31/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 9,470 | $761K | 11/30/2025 | View on chart |
| CVS | ▲ Buy | Grant | 11,768 | $800K | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Grant | 83,542 | $5.0M | 11/30/2024 | View on chart |
| CVS | ▲ Buy | Open Market | 35 | $2K | 10/23/2024 | View on chart |
| CVS | ▲ Buy | Open Market | 10 | $622 | 10/2/2024 | View on chart |
| CVS | ▲ Buy | Open Market | 35 | $2K | 9/9/2024 | View on chart |
| MCD | ▲ Buy | Option Exercise | 630 | $0 | 5/28/2024 | View on chart |
| MCD | ▼ Sell | Tax Withholding | 3,213 | $815K | 5/28/2024 | View on chart |
| MCD | ▲ Buy | Option Exercise | 6,623 | $0 | 5/28/2024 | View on chart |
| MCD | ▲ Buy | Option Exercise | 12,956 | $0 | 2/16/2024 | View on chart |
| MCD | ▼ Sell | Tax Withholding | 5,621 | $1.6M | 2/16/2024 | View on chart |
| MCD | ▲ Buy | Option Exercise | 894 | $0 | 2/16/2024 | View on chart |
| MCD | ▼ Sell | Open Market | 2,750 | $814K | 12/29/2023 | View on chart |
| MCD | ▼ Sell | Open Market | 687 | $195K | 12/1/2023 | View on chart |
| MCD | ▼ Sell | Open Market | 687 | $181K | 11/1/2023 | View on chart |
| MCD | ▼ Sell | Open Market | 688 | $180K | 10/2/2023 | View on chart |
| MCD | ▼ Sell | Open Market | 688 | $194K | 9/1/2023 | View on chart |
| MCD | ▼ Sell | Gift | 354 | $0 | 8/31/2023 | View on chart |
| MCD | ▲ Buy | Option Exercise | 7,241 | $0 | 5/28/2023 | View on chart |
| MCD | ▲ Buy | Option Exercise | 513 | $0 | 5/28/2023 | View on chart |
| MCD | ▼ Sell | Tax Withholding | 3,413 | $976K | 5/28/2023 | View on chart |
| MCD | ▲ Buy | Option Exercise | 10,597 | $0 | 5/28/2022 | View on chart |
| MCD | ▼ Sell | Other | 311 | $0 | 5/28/2022 | View on chart |
| MCD | ▼ Sell | Tax Withholding | 3,073 | $774K | 5/28/2022 | View on chart |
| MCD | ▼ Sell | Other | 497 | $0 | 5/28/2022 | View on chart |
| MCD | ▼ Sell | Tax Withholding | 4,915 | $1.2M | 5/28/2022 | View on chart |
| MCD | ▲ Buy | Option Exercise | 6,624 | $0 | 5/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.